ORBIMED ADVISORS LLC - 30 Jun 2025 SCHEDULE 13G/A Report for X4 Pharmaceuticals, Inc Common Stock, par value $0.001 per share (XFOR)

Filing Manager: ORBIMED ADVISORS LLC
Reporting Manager: ORBIMED ADVISORS LLC
Security: X4 Pharmaceuticals, Inc Common Stock, par value $0.001 per share
Symbol: XFOR
Shares outstanding: 7,938,059 shares
Disclosed Ownership: 134,947 shares
Ownership: 1.7%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 17:53:08 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
ORBIMED ADVISORS LLC	1.7%	134,947	0	134,947	/s/ Carl L. Gordon	Carl L. Gordon, Member